migraine
We propose that activation of MAPK pathways may increase CGRP gene expression during migraine, and that sumatriptan can diametrically oppose that activation via a prolonged elevation of intracellular calcium.
We propose that activation of MAPK pathways may increase <span class="gene" id="12574409-10-57-61">CGRP</span> gene expression during <span class="disease" id="12574409-10-85-93">migraine</span>, and that sumatriptan can diametrically oppose that activation via a prolonged elevation of intracellular calcium.